Serimmune Inc.

Doing business as Serimmune Inc.

UEI
QLNXP9AN7H58
CAGE
78YZ7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
serimmune.com
Founded
2014
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Serimmune Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Serum antibody biomarkers of myalgic encephalomyelitis/chronic fatigue syndrome Grant · R43AI145696 National Institute of Allergy and Infectious Diseases $224,975
Digital serology for parallel parasitic disease detection Grant · R43AI129113 National Institutes of Health $224,950
Digital serology panel for multiplex tick-borne disease testing Grant · R44GM119873 National Institute of General Medical Sciences $2,253,874
Display-SEQ: a platform for NGS-based serological testing Grant · R43GM119873 National Institutes of Health $224,774
Epitope motifs from 3 causes of cerbral parasitiosis Contract · HHSD2002016M90217P CDC Pittsburgh $45,750

Quick answers

What is Serimmune Inc.'s UEI?

Serimmune Inc.'s Unique Entity ID (UEI) in SAM.gov is QLNXP9AN7H58.

What is Serimmune Inc.'s CAGE code?

Serimmune Inc.'s CAGE code is 78YZ7.

What is Serimmune Inc.'s primary NAICS code?

Serimmune Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Serimmune Inc. registered in SAM.gov?

Serimmune Inc.'s SAM.gov registration expired on May 14, 2025.

What is Serimmune Inc.'s most recent federal award?

Serimmune Inc.'s most recent federal grant award is Serum antibody biomarkers of myalgic encephalomyelitis/chronic fatigue syndrome (R43AI145696), from National Institute of Allergy and Infectious Diseases, on April 1, 2019.

On GovTribe

See Serimmune Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login